Arvind Dasari

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.5Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Survival According to Primary Tumor Location, Stage, and Treatment Patterns in Locoregional Gastroenteropancreatic High-grade Neuroendocrine Carcinomas

The Oncologist(2022)10.1093/oncolo/oyab039

Top 15%

1.4DataRank

Top 15%46 citations

Chan Shen, Anjali Devabhaktuni, Ruda Nighot, Halfdan Sørbye, Arvind Dasari

Papers

Driven by 37 papers — median percentile 82. Top paper: “Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors”.

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

New England Journal of Medicine(2024)10.1056/nejmoa2403991

N/A

3.0DataRank · unranked

141 citations

Susan M. Geyer, Tyler Zemla, Michael V. Knopp, Spencer C. Behr, Sydney Pulsipher +19 more

Survival According to Primary Tumor Location, Stage, and Treatment Patterns in Locoregional Gastroenteropancreatic High-grade Neuroendocrine Carcinomas

The Oncologist(2022)10.1093/oncolo/oyab039

Top 15%

1.4DataRank

Top 15%46 citations

Chan Shen, Anjali Devabhaktuni, Ruda Nighot, Halfdan Sørbye, Arvind Dasari

Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors

JAMA Oncology(2022)10.1001/jamaoncol.2022.0212

N/A

1.1DataRank · unranked

40 citations

Suyu Liu, Arvind Dasari, David R. Fogelman, Priya Bhosale, Armeen Mahvash +21 more

Epidemiology of Neuroendocrine Neoplasms in the US

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.15798

Top 18%

1.1DataRank

Top 18%72 citations

Katrine L. Wallace, Daniel M. Halperin, Jessica Maxwell, Pamela L. Kunz, Simron Singh +3 more

Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer

BMC Cancer(2024)10.1186/s12885-024-12529-7

N/A

0.808DataRank · unranked

39 citations

Qian Shi, Arvind Dasari, Julio García‐Aguilar, Hanna Sanoff, Thomas J. George +25 more

Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial

Journal of Clinical Oncology(2025)10.1200/jco-24-01710

N/A

0.458DataRank · unranked

9 citations

Katherine A. Guthrie, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih, Michael J. Overman +15 more

Phase I trial of single-photon emission computed tomography–guided liver-directed radiotherapy for patients with low functional liver volume

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae037

N/A

0.340DataRank · unranked

6 citations

Franklin C. Wong, Beth Chasen, William D. Erwin, Prajnan Das, Emma B. Holliday +27 more

NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps212

N/A

0.312DataRank · unranked

7 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +8 more

Utilizing Patient Input in Rectal Cancer Trial Design

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf074

N/A

0.241DataRank · unranked

4 citations

Wini Zambare, Manju George, Reese Garcia, Phuong Gallagher, Caleah Kitchens +22 more

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps3643

N/A

0.208DataRank · unranked

3 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +9 more

NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad143

N/A

0.165DataRank · unranked

2 citations

Rebecca C. Auer, May Cho, N.A. Dasari, Cynthia Davies-Venn, Cathy Eng +36 more

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3634

N/A

0.104DataRank · unranked

1 citations

Yu Guan, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Ibrahim Halil Sahin +10 more

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad096

N/A

0DataRank · unranked

9 citations

Thomas A. Hope, Emily B Bergsland, Lisa Bodei, David Bushnell, Jennifer A. Chan +63 more

Alliance A022104/NRG-GI010: A randomized phase II trial testing the efficacy of triplet versus doublet chemotherapy to achieve clinical complete response in patients with locally advanced rectal cancer—The Janus Rectal Cancer trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3640

N/A

0DataRank · unranked

21 citations

Arvind Dasari, Qian Shi, Julio García‐Aguilar, Hanna K. Sanoff, Thomas J. George +13 more

Utility of circulating tumor DNA (ctDNA) in the management of appendiceal adenocarcinoma (AA).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.226

N/A

0DataRank · unranked

8 citations

Fadl A. Zeineddine, Abdelrahman Yousef, Julia Dansby, Michael G. White, Michael J. Overman +7 more

A randomized phase 2 study of trastuzumab and pertuzumab (TP) compared to cetuximab and irinotecan (CETIRI) in advanced/metastatic colorectal cancer (mCRC) with HER2 amplification: SWOG S1613.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.140

N/A

0DataRank · unranked

7 citations

Katherine A. Guthrie, Scott Kopetz, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih +15 more

NRG GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps260

N/A

0DataRank · unranked

0 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +10 more

Data from Oxidative Stress Induces Premature Senescence by Stimulating Caveolin-1 Gene Transcription through p38 Mitogen-Activated Protein Kinase/Sp1–Mediated Activation of Two GC-Rich Promoter Elements

(2023)10.1158/0008-5472.c.6494898.v1

N/A

0DataRank · unranked

0 citations

Janine N. Bartholomew, Daniela Volonté, Ferruccio Galbiati, Arvind Dasari

Data from Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

(2023)10.1158/2767-9764.c.6550830.v1

N/A

0DataRank · unranked

0 citations

Michael J. Overman, Michael Hon‐Wah Lam, Christine M. Parseghian, Benny Johnson, Arvind Dasari +17 more

Is there an increase in elective utilization of non-operative management for rectal cancer?

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e15533

N/A

0DataRank · unranked

0 citations

Chung‐Yuan Hu, Abhineet Uppal, Oliver Peacock, Brian K. Bednarski, Tsuyoshi Konishi +13 more

Data from Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

(2023)10.1158/2767-9764.c.6975005.v1

Top 100%

0DataRank

Top 100%0 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Perioperative and oncological outcomes following robotic en bloc multivisceral resection for colorectal cancer

Colorectal Disease(2024)10.1111/codi.16964

N/A

0DataRank · unranked

9 citations

Naveen Manisundaram, Young Wan Kim, Oliver Peacock, Chung‐Yuan Hu, Brian K. Bednarski +10 more

Physical activity and dexamethasone for cancer related fatigue: A preliminary placebo controlled randomized control trial.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.12050

N/A

0DataRank · unranked

0 citations

Vicente Valero, Brandon G. Smaglo, Michael J. Overman, Arvind Dasari, Robert A. Wolff +8 more

Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer

Cancer Cell(2025)10.1016/j.ccell.2025.08.002

N/A

0DataRank · unranked

22 citations

Christine M. Parseghian, Vahid Bahrambeigi, Nourhan Abdelfattah, Lianchun Xiao, Anjali Agrawal +28 more

Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa034

N/A

0DataRank · unranked

114 citations

Dawn L. Hershman, Raymond U. Osarogiagbon, Anirudh Gothwal, Seerat Anand, Arvind Dasari +4 more

Prospective longitudinal trajectory of cancer survivorship among patients with recurrent rectal cancer: impact of treatment modalities and resection status

Colorectal Disease(2025)10.1111/codi.70110

N/A

0DataRank · unranked

3 citations

Oliver Peacock, Brian K. Bednarski, Arvind Dasari, Prajnan Das, Benny Johnson +5 more

Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases

Journal of Gastrointestinal Surgery(2020)10.1007/s11605-020-04866-2

N/A

0DataRank · unranked

28 citations

Timothy E. Newhook, Hop S. Tran Cao, Ching‐Wei D. Tzeng, Yun Shin Chun, Thomas A. Aloia +4 more

Incidence of Lymph Node Metastases and Impact of Radical Surgery for Duodenal Neuroendocrine Tumors

Journal of Surgical Research(2021)10.1016/j.jss.2021.06.085

N/A

0DataRank · unranked

5 citations

Ching‐Wei D. Tzeng, Yi-Ju Chiang, Daniel M. Halperin, Arvind Dasari, Michael P. Kim +4 more

Phase II trial of bintrafusp alfa in patients with metastatic MSI-H cancers following progression on immunotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.79

N/A

0DataRank · unranked

15 citations

Michael Lam, Xuemei Wang, Michael J. Overman, Benny Johnson, Bryan K. Kee +7 more

The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer

Clinical Colorectal Cancer(2022)10.1016/j.clcc.2022.03.004

N/A

0DataRank · unranked

25 citations

Shreya Raghavan, Arvind Dasari, Scott Kopetz, Alisha Bent

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience

The Oncologist(2022)10.1093/oncolo/oyac162

N/A

0DataRank · unranked

21 citations

Jane E. Rogers, Hyunsoo Hwang, Wei Qiao, Lianchun Xiao, Arvind Dasari +11 more

Clinical and pathologic features correlated with rare favorable survival in patients with BRAFV600E mutated colorectal cancer

Journal of Gastrointestinal Oncology(2022)10.21037/jgo-21-471

N/A

0DataRank · unranked

4 citations

Bryan K. Kee, Michael J. Overman, Arvind Dasari, Kanwal Raghav, Benny Johnson +6 more

Randomized phase II trial of postoperative adjuvant capecitabine and temozolomide versus observation in high-risk pancreatic neuroendocrine tumors: SWOG S2104.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps515

N/A

0DataRank · unranked

9 citations

Katherine A. Guthrie, Syed A. Ahmad, M. Kay Washington, Brian Hemendra Ramnaraign, Nitya Raj +8 more

Phase 2 study of anti-EGFR rechallenge therapy with panitumumab with or without trametinib in advanced colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3520

N/A

0DataRank · unranked

9 citations

Eduardo Vilar Sanchez, Ryan Sun, Madhulika Eluri, Van K. Morris, Benny Johnson +11 more

RAS co-mutation and early onset disease represent an aggressive phenotype of atypical (non-V600) BRAF mutant metastatic colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3592

N/A

0DataRank · unranked

0 citations

Dongyun Yang, Hiba I. Dada, Van K. Morris, Xuemei Wang, Arvind Dasari +14 more

Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0340

N/A

0DataRank · unranked

15 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Bioprosthetic valve monitoring in patients with carcinoid heart disease

Frontiers in Cardiovascular Medicine(2023)10.3389/fcvm.2022.1072890

N/A

0DataRank · unranked

5 citations

Saamir Hassan, Anita Deswal, Joerg Herrmann, Juhee Song, Dominique Monlezun +17 more

Arvind Dasari

Indexed papers

Top data-sharing exemplar

Papers